Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Fogel

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Respiratory Research|June 22, 2018
Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME studyAntonio R Anzueto, Konstantinos Kostikas, Karen Mezzi, et al.
Lung|October 11, 2017
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over StudiesEdward Kerwin, Gary T Ferguson, Shahin Sanjar, et al.
NPJ Primary Care Respiratory Medicine|October 30, 2019
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort studyDavid B Price, Jaco Voorham, Guy Brusselle, et al.
Respiratory Research|August 9, 2019
Evaluation of exacerbations and blood eosinophils in UK and US COPD populationsClaus F Vogelmeier, Konstantinos Kostikas, Juanzhi Fang, et al.
Respiratory Research|January 10, 2019
Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME studyJadwiga A Wedzicha, Dave Singh, Ioanna Tsiligianni, et al.
Pulmonary Pharmacology & Therapeutics|December 27, 2017
Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary diseaseJames F Donohue, Paul W Jones, Christian Bartels, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 23, 2018
Gender-specific estimates of COPD prevalence: a systematic review and meta-analysisGeorgios Ntritsos, Jacob Franek, Lazaros Belbasis, et al.
Respiratory Research|July 15, 2026
Impact of benralizumab on airway structure/function in severe eosinophilic asthmaDonna D Carstens, Wilfried De Backer, Kirsty Rhodes, et al.
The New England Journal of Medicine|May 17, 2016
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPDJadwiga A Wedzicha, Donald Banerji, Kenneth R Chapman, et al.
American Journal of Respiratory and Critical Care Medicine|March 10, 2017
Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME TrialNicolas Roche, Kenneth R Chapman, Claus F Vogelmeier, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Respiratory Research|June 22, 2018
Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME studyAntonio R Anzueto, Konstantinos Kostikas, Karen Mezzi, et al.
Lung|October 11, 2017
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over StudiesEdward Kerwin, Gary T Ferguson, Shahin Sanjar, et al.
NPJ Primary Care Respiratory Medicine|October 30, 2019
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort studyDavid B Price, Jaco Voorham, Guy Brusselle, et al.
Respiratory Research|August 9, 2019
Evaluation of exacerbations and blood eosinophils in UK and US COPD populationsClaus F Vogelmeier, Konstantinos Kostikas, Juanzhi Fang, et al.
Respiratory Research|January 10, 2019
Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME studyJadwiga A Wedzicha, Dave Singh, Ioanna Tsiligianni, et al.
Pulmonary Pharmacology & Therapeutics|December 27, 2017
Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary diseaseJames F Donohue, Paul W Jones, Christian Bartels, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 23, 2018
Gender-specific estimates of COPD prevalence: a systematic review and meta-analysisGeorgios Ntritsos, Jacob Franek, Lazaros Belbasis, et al.
Respiratory Research|July 15, 2026
Impact of benralizumab on airway structure/function in severe eosinophilic asthmaDonna D Carstens, Wilfried De Backer, Kirsty Rhodes, et al.
The New England Journal of Medicine|May 17, 2016
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPDJadwiga A Wedzicha, Donald Banerji, Kenneth R Chapman, et al.
American Journal of Respiratory and Critical Care Medicine|March 10, 2017
Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME TrialNicolas Roche, Kenneth R Chapman, Claus F Vogelmeier, et al.
Pageof 4